Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer

Pemetrexed is a new cytotoxic agent that is a standard of care for the second-line treatment of non-small cell lung cancer (NSCLC) and in combination with cisplatin in treatment of malignat pleural mesothelioma. It has been studied in numerous phase II and III trials in combination with different dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricciardi, Serena, Tomao, Silverio, de Marinis, Filippo
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762436/
https://www.ncbi.nlm.nih.gov/pubmed/19851525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762436/
https://www.ncbi.nlm.nih.gov/pubmed/19851525

Ejemplares similares